108 related articles for article (PubMed ID: 29783295)
1. Healthcare payers: a gate or translational bridge to personalized medicine?
Canestaro WJ; Martell LA; Wassman ER; Schatzberg R
Per Med; 2012 Jan; 9(1):73-84. PubMed ID: 29783295
[TBL] [Abstract][Full Text] [Related]
2. PARC report: a perspective on the state of clinical pharmacogenomics testing.
Eichmeyer J; Rogers S; Formea CM; Giri J; Jones JS; Schnettler E; Schmidlen T; Glogowski E; Kurz RN
Pharmacogenomics; 2020 Jul; 21(11):809-820. PubMed ID: 32635876
[TBL] [Abstract][Full Text] [Related]
3. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.
Trosman JR; Weldon CB; Schink JC; Gradishar WJ; Benson AB
J Comp Eff Res; 2013 Jul; 2(4):461-77. PubMed ID: 24236686
[TBL] [Abstract][Full Text] [Related]
4. Payer view of personalized medicine.
Pezalla EJ
Am J Health Syst Pharm; 2016 Dec; 73(23):2007-2012. PubMed ID: 27864208
[TBL] [Abstract][Full Text] [Related]
5. Innovative payer engagement strategies: will the convergence lead to better value creation in personalized medicine?
Akhmetov I; Bubnov RV
EPMA J; 2017 Dec; 8(1):5-15. PubMed ID: 28228864
[TBL] [Abstract][Full Text] [Related]
6. An inter-professional approach to personalized medicine education: one institution's experience.
Formea CM; Nicholson WT; Vitek CR
Per Med; 2015 Mar; 12(2):129-138. PubMed ID: 28413426
[TBL] [Abstract][Full Text] [Related]
7. Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.
Frueh FW
Value Health; 2013; 16(6 Suppl):S27-31. PubMed ID: 24034309
[TBL] [Abstract][Full Text] [Related]
8. Overcoming regulatory and economic challenges facing pharmacogenomics.
Cohen JP
N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
[TBL] [Abstract][Full Text] [Related]
9. Guidelines and Value-Based Decision Making: An Evolving Role for Payers.
McCauley JL
N C Med J; 2015; 76(4):243-6. PubMed ID: 26509518
[TBL] [Abstract][Full Text] [Related]
10. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research.
Siebert U; Jahn B; Rochau U; Schnell-Inderst P; Kisser A; Hunger T; Sroczynski G; Mühlberger N; Willenbacher W; Schnaiter S; Endel G; Huber L; Gastl G;
Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):330-40. PubMed ID: 26354133
[TBL] [Abstract][Full Text] [Related]
11. Translational strategies to implement personalized medicine: rheumatoid arthritis examples.
Littman BH
Per Med; 2009 Jul; 6(4):429-437. PubMed ID: 29783543
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and health economic challenges of personalized medicine].
Brüggenjürgen B; Kornbluth L; Ferrara JV; Willich SN
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):710-4. PubMed ID: 22526860
[TBL] [Abstract][Full Text] [Related]
13. A coalition to drive personalized medicine forward.
Munroe JB
Per Med; 2004 Dec; 1(1):9-13. PubMed ID: 29793218
[TBL] [Abstract][Full Text] [Related]
14. Company Profile: Center for Business Models in Healthcare.
Trosman JR; Weldon CB
Per Med; 2013 Jun; 10(4):333-337. PubMed ID: 29783420
[TBL] [Abstract][Full Text] [Related]
15. Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare.
Simmons LA; Dinan MA; Robinson TJ; Snyderman R
Per Med; 2012 Jan; 9(1):85-91. PubMed ID: 29783292
[TBL] [Abstract][Full Text] [Related]
16. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
O'Donnell JC
Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
[TBL] [Abstract][Full Text] [Related]
17. Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine.
Akhmetov I; Bubnov RV
EPMA J; 2015; 6():19. PubMed ID: 26425215
[TBL] [Abstract][Full Text] [Related]
18. Economic incentives for evidence generation: promoting an efficient path to personalized medicine.
Towse A; Garrison LP
Value Health; 2013; 16(6 Suppl):S39-43. PubMed ID: 24034311
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
